These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18072496)

  • 61. Optimization of light sources for prostate photodynamic therapy.
    Altschuler MD; Zhu TC; Li J; Hahn SM
    Proc SPIE Int Soc Opt Eng; 2005 Apr; 5689():186-197. PubMed ID: 26136612
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A strategy to objectively evaluate the necessity of correcting detected target deviations in image guided radiotherapy.
    Yue NJ; Kim S; Jabbour S; Narra V; Haffty BG
    Med Phys; 2007 Nov; 34(11):4340-7. PubMed ID: 18072499
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A gEUD-based inverse planning technique for HDR prostate brachytherapy: feasibility study.
    Giantsoudi D; Baltas D; Karabis A; Mavroidis P; Zamboglou N; Tselis N; Shi C; Papanikolaou N
    Med Phys; 2013 Apr; 40(4):041704. PubMed ID: 23556874
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dose-shaping using targeted sparse optimization.
    Sayre GA; Ruan D
    Med Phys; 2013 Jul; 40(7):071711. PubMed ID: 23822415
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.
    Patel H; Mick R; Finlay J; Zhu TC; Rickter E; Cengel KA; Malkowicz SB; Hahn SM; Busch TM
    Clin Cancer Res; 2008 Aug; 14(15):4869-76. PubMed ID: 18676760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.
    Cantin A; Gingras L; Lachance B; Foster W; Goudreault J; Archambault L
    Med Phys; 2015 Dec; 42(12):7011-21. PubMed ID: 26632056
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A voxel-dose algorithm of heterogeneous activity distribution for Monte-Carlo simulation of radionuclide therapy dosimetry.
    Lin H; Jing J; Cai J; Xu L
    Cancer Biother Radiopharm; 2012 Aug; 27(6):344-52. PubMed ID: 22804457
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Feasibility of using ultrasound for real-time tracking during radiotherapy.
    Hsu A; Miller NR; Evans PM; Bamber JC; Webb S
    Med Phys; 2005 Jun; 32(6):1500-12. PubMed ID: 16013706
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pilot study on light dosimetry for endobronchial photodynamic therapy.
    Marijnissen JP; Baas P; Beek JF; van Moll JH; van Zandwijk N; Star WM
    Photochem Photobiol; 1993 Jul; 58(1):92-9. PubMed ID: 8378437
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment system for whole bladder wall photodynamic therapy with in vivo monitoring and control of light dose rate and dose.
    Marynissen JP; Jansen H; Star WM
    J Urol; 1989 Nov; 142(5):1351-5. PubMed ID: 2810531
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intra-cavity Photodynamic Therapy for malignant tumors of the paranasal sinuses: An in vivo light dosimetry study.
    van Doeveren TEM; van Veen RLP; van den Boom F; Tan IB; Schreuder WH; Karakullukçu MB
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101972. PubMed ID: 32835881
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of optical properties in heterogeneous turbid media using a cylindrical diffusing fiber.
    Dimofte A; Finlay JC; Liang X; Zhu TC
    Phys Med Biol; 2012 Oct; 57(19):6025-46. PubMed ID: 22968172
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An interstitial light assembly for photodynamic therapy in prostatic carcinoma.
    Lee LK; Whitehurst C; Pantelides ML; Moore JV
    BJU Int; 1999 Nov; 84(7):821-6. PubMed ID: 10532979
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Feasibility study of a system for combined light dosimetry and interstitial photodynamic treatment of massive tumors.
    Johansson T; Thompson MS; Stenberg M; af KC; Andersson-Engels S; Svanberg S; Svanberg K
    Appl Opt; 2002 Mar; 41(7):1462-8. PubMed ID: 11900027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A fast heterogeneous algorithm for light fluence rate for prostate photodynamic therapy.
    Chang C; Wang KK; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2010 Mar; 7551():. PubMed ID: 26005241
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Photodynamic therapy.
    Grossweiner LI
    J Laser Appl; 1995 Mar; 7(1):51-7. PubMed ID: 10155129
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel flexible light diffuser and irradiation properties for photodynamic therapy.
    Selm B; Rothmaier M; Camenzind M; Khan T; Walt H
    J Biomed Opt; 2007; 12(3):034024. PubMed ID: 17614732
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.
    Zhu TC; Altschuler MD; Hu Y; Wang K; Finlay JC; Dimofte A; Cengel K; Hahn SM
    Proc SPIE Int Soc Opt Eng; 2010 Jan; 7551():. PubMed ID: 25995533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.